COVID-19 Vaccine Distribution and Delta Variant

COVID-19 Vaccine Distribution and Delta Variant

Assessment

Interactive Video

Science, Biology, Health, Social Studies

9th - 12th Grade

Hard

Created by

Liam Anderson

FREE Resource

Gavi has signed agreements with Sinopharm and Sinovac to produce over 100 million COVID-19 vaccine doses for COVAX. This move comes as the Delta variant increases health risks globally.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which organization has signed agreements with Sinopharm and Sinovac?

United Nations

Centers for Disease Control and Prevention

Gavi, the Vaccine Alliance

World Health Organization

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the purpose of the agreements with Sinopharm and Sinovac?

To distribute vaccines in China only

To develop new vaccine technology

To produce over 100 million vaccine doses

To conduct vaccine research

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many COVID-19 vaccine doses will be made available to the COVAX facility?

75 million

100 million

150 million

50 million

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is the purchase of vaccines considered timely?

Due to a shortage of vaccines

Because of the rising risk of the Delta variant

To meet the demands of a new pandemic

To support local health systems

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is posing a rising risk to health systems according to Gavi?

The Gamma variant

The Delta variant

The Beta variant

The Alpha variant